De-risking clinical development of precision medicines in oncology and rare disease
What is new
Treating Untreatable Cancer
THE CHALLENGE
For decades, various neuromodulation technologies have focused on neuropathic pain while nociceptive was largely overlooked. Many chronic nociceptive pain patients endure failed treatment after failed treatment.
Current available treatments
And up to 40% of surgery
often fail to achieve at least 50% pain relief.1
often fail to achieve at least 50% pain relief.1
Driving Change for People With Cancer and Rare Disease
We came to Geventis to solve the unsolvable. We stay to create new possibilities and grow together. We work fearlessly and go beyond because we care deeply about making a difference and changing lives. If you are inspired by helping others, driven to discover transformative medicines, and want a career that can make a difference, we want to hear from you!
THE CHALLENGE
Innovative Science
Genventis’s Innovation Science platform combines molecular biology, computational modeling, and translational research to advance precision therapies in Oncology, Neurology, Immunology, and Rare Diseases—targeting complex disease mechanisms to improve patient outcomes.
In Oncology, Neurology, Autoimmune/Immune, and Rare Disease research, Genventis applies deep expertise in cellular engineering, immune modulation, and neurocircuit analysis to translate discovery into meaningful therapeutics. By combining innovative science with clinical insight, we aim to transform the way diseases are treated—delivering targeted, durable, and life-changing therapies for patients worldwide.
THE GENVENTIS DIFFERENCE
Inhibiting Neurons. Unleashing a New Wave in Treating Respiratory.
GVT is designed to make waves in helping patients with untreatable nociceptive pain and other diseases of undesired neural activity. The journey is just beginning!
The Future with GVT
GVT is designed to make waves in helping patients with untreatable nociceptive pain and other diseases of undesired neural activity. The journey is just beginning!
Explore our stories
Innovation
What is One Pipeline
Explore our science
How Geventis scientists are driving generation cancer research
Patients
Podcast: A candid conversation about diversity in clinical trials
Press releases
Environmental, Social & Governance (ESG)
Find out how we're supporting the future of our business and the well-being of patients, people, and communities around the world.
Media
Our latest news, announcements and multimedia resources
Sustainability
Our science-led strategy is key to delivering long-term value for patients, employees, and shareholders.
